drugset / Trial / NCT01115426
Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study evaluates prospectively the effects of an anti-angiotensin II regimen on renal outcome in patients with mesangioproliferative glomerulonephritis followed-up for 10 years.
Timeline
- Start
- 1997-01
- Primary completion
- 2007-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 50 mg | — |
| Subject | Ramipril | Small molecule | 5 mg | — |